Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02454270
Title A Dose Escalation Study of JNJ-64052781 in Participants With Relapsed or Refractory B-cell Malignancies
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

diffuse large B-cell lymphoma

follicular lymphoma

acute lymphoblastic leukemia

chronic lymphocytic leukemia

mantle cell lymphoma

Therapies

JNJ-64052781

Age Groups: adult
Covered Countries USA | FRA | ESP | BEL

Facility Status City State Zip Country Details
Detroit Michigan United States Details
New York New York United States Details
Columbus Ohio United States Details
Philadelphia Pennsylvania United States Details
Nashville Tennessee United States Details
Houston Texas United States Details
Edegem Belgium Details
Leuven Belgium Details
Wilrijk Belgium Details
Lille France Details
Pierre Benite France Details
Rennes France Details
Tours Cedex France Details
Haifa Israel Details
Jerusalem Israel Details
Ramat Gan Israel Details
Tel Aviv Israel Details
Barcelona Spain Details
Madrid Spain Details
Salamanca Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field